Panbela Therapeutics (PBLA) Stock Chart & Stock Price History $0.35 -0.01 (-2.78%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends Panbela Therapeutics Stock Price Performance 5 Day Performance+8.93%1 Month Performance+4.78%3 Month Performance+1.23%6 Month Performance-2.99%Year-To-Date Performance-98.09%1 Year Performance-96.52% Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address A “Thank You Gift” From Pres. Trump - Genius (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide PBLA Stock Chart for Sunday, November, 24, 2024 PBLA Chart by TradingView Panbela Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$0.36$0.35-2.34%$0.36$0.3212,340 shs$1.69 million11/21/2024$0.32$0.36+11.51%$0.36$0.331,864 shs$1.73 million11/20/2024$0.32$0.32+0.03%$0.32$0.324,285 shs$1.56 million11/19/2024$0.32$0.32+0.03%$0.32$0.323,638 shs$1.56 million11/18/2024$0.33$0.32-1.46%$0.33$0.326,727 shs$1.55 million11/15/2024$0.30$0.33+8.07%$0.37$0.3020,485 shs$1.13 million Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$0.32$0.30-5.35%$0.33$0.3018,845 shs$1.05 million11/13/2024$0.34$0.32-6.47%$0.34$0.322,586 shs$1.11 million11/12/2024$0.34$0.34$0.34$0.323,956 shs$1.18 million11/11/2024$0.33$0.34+4.29%$0.35$0.327,555 shs$1.18 million11/08/2024$0.34$0.33-4.29%$0.35$0.322,471 shs$1.13 million11/07/2024$0.32$0.34+7.04%$0.34$0.321,028 shs$1.19 million11/06/2024$0.36$0.32-10.87%$0.35$0.3213,006 shs$1.11 million11/05/2024$0.37$0.36-3.51%$0.37$0.32777 shs$1.24 million11/04/2024$0.37$0.37$0.37$0.37600 shs$1.29 million11/01/2024$0.37$0.37+0.68%$0.37$0.37616 shs$1.29 million10/31/2024$0.38$0.37-3.29%$0.37$0.322,154 shs$1.28 million10/30/2024$0.32$0.38+18.75%$0.38$0.324,007 shs$1.32 million10/29/2024$0.34$0.32-6.57%$0.38$0.326,175 shs$1.11 million10/28/2024$0.35$0.34-2.14%$0.35$0.322,426 shs$1.19 million10/25/2024$0.33$0.35+5.01%$0.35$0.324,424 shs$1.22 million10/24/2024$0.33$0.33+1.00%$0.38$0.328,109 shs$1.16 million10/23/2024$0.34$0.33-3.92%$0.34$0.321,455 shs$1.15 million Related Companies Edesa Biotech Stock Chart Eyenovia Stock Chart GT Biopharma Stock Chart Evoke Pharma Stock Chart Adial Pharmaceuticals Stock Chart TransCode Therapeutics Stock Chart IM Cannabis Stock Chart Virax Biolabs Group Stock Chart Vaccinex Stock Chart Ainos Stock Chart Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBLA) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.